These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 989388)

  • 1. Identification of opiate/receptor binding in vivo.
    Höllt V; Haarmann I; Herz A
    Arzneimittelforschung; 1976; 26(6):1102-4. PubMed ID: 989388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo receptor binding of opioid drugs at the mu site.
    Rosenbaum JS; Holford NH; Sadée W
    J Pharmacol Exp Ther; 1985 Jun; 233(3):735-40. PubMed ID: 2989495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF; Nishimura S; Goodman RR; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etorphine binds to multiple opiate receptors of the caudate nucleus with equal affinity but with different kinetics.
    Tolkovsky AM
    Mol Pharmacol; 1982 Nov; 22(3):648-56. PubMed ID: 6296657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro.
    Pasternak GW; Childers SR; Snyder SH
    J Pharmacol Exp Ther; 1980 Sep; 214(3):455-62. PubMed ID: 6105201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
    Yoburn BC; Purohit V; Patel K; Zhang Q
    Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.
    Martin BR; Katzen JS; Woods JA; Tripathi HL; Harris LS; May EL
    J Pharmacol Exp Ther; 1984 Dec; 231(3):539-44. PubMed ID: 6094791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
    Townsend D; Portoghese PS; Brown DR
    J Pharmacol Exp Ther; 2004 Jan; 308(1):385-93. PubMed ID: 14569065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone binding at nonopiate receptor binding sites.
    Ciofalo FR
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):419-30. PubMed ID: 451332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
    Zernig G; Burke T; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination of three types of opioid binding sites in rat brain in vivo.
    Rosenbaum JS; Holford NH; Richards ML; Aman RA; Sadée W
    Mol Pharmacol; 1984 Mar; 25(2):242-8. PubMed ID: 6321946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect.
    Simon EJ; Hiller JM; Groth J; Edelman I
    J Pharmacol Exp Ther; 1975 Mar; 192(3):531-7. PubMed ID: 235639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
    Castanas E; Giraud P; Audigier Y; Drissi R; Boudouresque F; Conte-Devolx B; Oliver C
    Mol Pharmacol; 1984 Jan; 25(1):38-45. PubMed ID: 6323951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine.
    Caruso TP; Larson DL; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1980 Jun; 213(3):539-44. PubMed ID: 6162947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
    Law PY; Hom DS; Loh HH
    Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain.
    Geary WA; Wooten GF
    J Pharmacol Exp Ther; 1983 Apr; 225(1):234-40. PubMed ID: 6300375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine: differential interaction with opiate receptor subtypes in vivo.
    Sadée W; Rosenbaum JS; Herz A
    J Pharmacol Exp Ther; 1982 Oct; 223(1):157-62. PubMed ID: 6288917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]1-(cyclopropylmethyl)-4-(2-(4-fluorophenyl)-2-oxoethyl) piperidine HBr (DuP 734). A selective ligand for sigma receptors in mouse brain in vivo.
    Watanabe M; Rominger D; Hurt SD; De Souza EB; Tam SW
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1541-8. PubMed ID: 8371156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.